Shanghai RAAS Joins the Haier Ecosystem!

On June 18, at the Haier Group's Healthcare Industry Ecosystem Integration Conference, with the theme "Shaping Tomorrow, Advancing Health," took place in Shanghai. We are delighted to welcome Shanghai RAAS as a new addition to the Haier ecosystem and embark on exploring the boundless opportunities within the healthcare sector together.

Greetings to Our Newest Members!

Haier Group successfully finalized its strategic investment in Shanghai RAAS Blood Products Co., Ltd. on June 18, marking a significant milestone in Haier Group's journey within the healthcare industry. With this investment, Shanghai RAAS officially becomes an integral part of Haier Group's healthcare ecosystem under the brand Incaier.

Established in 1988 and publicly listed on the Shenzhen Stock Exchange since 2008, Shanghai RAAS stands as a prominent blood products provider in China. It is renowned for its ability to extract six components from plasma and is a leading producer of blood coagulation factor products in the domestic market.

As previously communicated, through Haiyingkang (Qingdao) Medical Technology Co., Ltd., Haier Group completed the acquisition of a 20% stake in Shanghai RAAS from global healthcare company Grifols for RMB 12.5 billion. Following this transaction, Haiyingkang will hold a total voting rights share of 26.58%, making Haier Group the actual controlling entity post-reorganization of Shanghai RAAS’s board.

A Unified Ecosystem for Collective Progress

Remaining steadfastly anchored in real-world industries, Haier Group has delineated three core sectors: smart home solutions, healthcare innovations, and industrial internet advancements. Within healthcare endeavours lies Incaier – our dedicated ecosystem brand designed for fostering collaborative growth.

Operating within an interconnected ecosystem ethos enables us to pool resources with partners like Shanghai RAAS across user engagement strategies, management methodologies, global networking systems, industrial digitalization practices, and branding initiatives. This partnership aims to bolster Shanghai RAAS’s dual strategy focusing on plasma resource expansion and non-plasma avenues while upholding standards of safety, quality assurance, and operational efficiency.

Chairman and CEO of Haier Group Zhou Yunjie expressed:

"During our four-decade journey at Haier, we have consistently aligned with global trends and user needs by propelling high-quality advancements through innovation — culminating into a globally recognized enterprise marked by pioneering management principles."

Vice Chairman Tan Lixia added:

"Collaboration between Incair entities like Haier Biomedical and now jointly with Shanghai RAAS will revolutionize life sciences research delivery systems globally."

Preserving Aspirations Through Timeless Commitments

At its core essence lies the people - individuals who are instrumental to any enterprise; culture serves as its soulful voice resonating through time immemorial. Throughout its illustrious history spanning four decades, Haier remains committed to championing individual value maximization principles that resonate across all strata within their growing family – now enriched by an additional workforce comprising 3190 talents from Shanghai RAAS.

During this momentous gathering, three delegates from Shanghai RAAS penned their visions onto parchment sealed within capsules symbolizing their unwavering commitment towards realizing individual potentialities thereby ensuring collective wellbeing transcends barriers into creating universal prosperity.

Redefining Future Horizons Through Developmental Leaps

Embarking upon this transformational odyssey, Incair and Shanghai RAAS biotech Park held grandiose festivities marking inception. With aspirations set skywards they aim at setting benchmarks within informationized realms indicative technologies transforming production base located at Fengxian District. This expansion not only meets burgeoning demands but lays solid groundworks facilitating emergence novel drugs beyond hematogenous purview.

"I see great prospects ahead as Shanghai RAAS ventures into future seamlessly integrating itself into the Haier family drawing strength strategic foresight unified efforts gaining wisdom harnessing relentless energies supporting hastened strides evolving health care landscapes aiming national well-being!" exclaimed Xu Jun-Chairman & GM amidst jubilant celebrations!

Together under one banner - Incair alongside Shanghai RAAS pledge allegiance empowering health care sectors striving collectively erect borderless ecosystems fostering global wellness!